★"常識とは１８歳までに身に付けた偏見のコレクションである" by Albert Einstein
常識を吟味し自問自答出来る奴は生きろ。政府の戯言を愚信し脳が同調圧力に侵されたマスク狂の奴はブースター接種して逝ってくれ。
英国政府は８月１６日、妊娠中の女性と授乳中の女性はファイザー製コロナワクチンを接種してはいけないと、公式文書で表明した（国民に大嘘がばれ、嘘を付き通すことが出来なくなった為か）。
★英国では、少しずつでも事実を国民に開示する様になったという事か？
日本も昨年の特例承認時には既に、様々な「毒性試験が存在していない」という事を知っていた筈。
・英国は、妊娠中や授乳中の女性へのＣＯＶＩＤ－１９ワクチン接種を抑制へ（禁止か？）
・方や日本は、妊娠中や授乳中の女性へのＣＯＶＩＤ－１９ワクチン接種を推奨（大いに打つべし）
★どうする日本？★
政府と偽称専門家は「妊娠中・授乳中の方も、ワクチンを接種することが出来ます」「日本で承認されているワクチンが、妊娠・胎児・母乳・生殖器に悪影響を及ぼすという報告はありません」と、未だに国民を騙し続けている。
（https://www.gov.uk/government/publications/regulatory-approval-of-pfizer-biontech-vaccine-for-covid-19/summary-public-assessment-report-for-pfizerbiontech-covid-19-vaccine）
Summary of the Public Assessment Report for COVID-19 Vaccine Pfizer/BioNTech Updated 16 August 2022
Applies to England, Scotland and Wales
The Public Assessment Report summarises the initial assessment at the time of approval in December 2020. The text in the original report remains unchanged.
...
...
Toxicity conclusions
The absence of reproductive toxicity data is a reflection of the speed of development to first identify and select COVID-19 mRNA Vaccine BNT162b2 for clinical testing and its rapid development to meet the ongoing urgent health need. In principle, a decision on licensing a vaccine could be taken in these circumstances without data from reproductive toxicity studies animals, but there are studies ongoing and these will be provided when available. In the context of supply under Regulation 174, it is considered that sufficient reassurance of safe use of the vaccine in pregnant women cannot be provided at the present time: however, use in women of childbearing potential could be supported provided healthcare professionals are advised to rule out known or suspected pregnancy prior to vaccination. Women who are breastfeeding should also not be vaccinated. These judgements reflect the absence of data at the present time and do not reflect a specific finding of concern. Adequate advice with regard to women of childbearing potential, pregnant women and breastfeeding women has been provided in both the Information for UK Healthcare Professionals and the Information for UK recipients.
